Search Results 21-30 of 17130 for egfr

  1. Kidney Transplant Program - Eligibility - Mayo Clinic

    Your comprehensive evaluation includes blood tests, imaging scans and other tests. Doctors check you for other serious conditions, including chronic infections, ...

  2. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

    An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors. Print details. Share ...

  3. Pulmonary Medicine - Clinical trials

    Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...

  4. Top 5 reasons to refer a patient early for kidney transplant - Mayo Clinic

    A transplant nephrologist at Mayo Clinic outlines suggested criteria for referring a patient for a potential kidney transplant.

  5. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) - Mayo Clinic

    Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR ...

  6. Pulmonary Medicine - Clinical trials

    Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...

  7. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations ... (EGFR) mutations. Erlotinib may ...

  8. Clinical trials - Oncology (Medical)

    Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...

  9. Pulmonary Medicine - Clinical trials

    Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...

  10. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now - Mayo Clinic

    ... EGFR mutant population. Patients will be enrolled over a three year period across approximately 25 geographically diverse academic as well as community ...